Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Council on Radionuclides and Radiopharmaceuticals (CORAR) is a non-profit trade association that represents the interests of companies involved in the manufacture, distribution, and use of radionuclides and radiopharmaceuticals. Based in Washington, D.C., the organization advocates for regulatory and legislative policies that support the growth and stability of the nuclear medicine industry. CORAR facilitates communication between its member companies and government agencies, such as the FDA and the Nuclear Regulatory Commission (NRC), to ensure the safe and efficient delivery of life-saving diagnostic and therapeutic products. Its membership includes leading global manufacturers of medical isotopes and radiopharmaceuticals. The association focuses on critical issues such as isotope supply chain security, transportation regulations, and healthcare reimbursement for nuclear medicine procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Council on Radionuclides and Radiopharmaceuticals.